Drug interactions with botanical products

Y. W.Francis Lam, Shiew Mei Huang, Stephen D. Hall

Producción científica: Chapter

3 Citas (Scopus)

Resumen

The use of botanicals by consumers in North American and European countries has significantly increased over the last decade, with one survey showing an almost 10% increase in usage from 1990 to 1997 (1). Although the efficacy of some botanicals has been documented (2), there is concern regarding the perceived safety of these products, particularly with respect to the lack of research and knowledge on botanical-drug interaction potential and significance (3). As more consumers use botanicals for various purposes, the likelihood of concurrent use of botanicals with prescription and/or over-the-counter medications, as well as the potential of pharmacokinetic and/or pharmacodynamic botanical-drug interactions will increase. The survey conducted by Eisenberg et al. (1) reported that as many as 15 million adults in 1997 took botanical supplements concurrently with prescription drugs. Over the subsequent years, there has been no change in this usage pattern, with as many as 16% of consumers surveyed indicating concurrent use of botanical dietary supplements and prescription drugs (4).

Idioma originalEnglish (US)
Título de la publicación alojadaHerbal Supplements-Drug Interactions
Subtítulo de la publicación alojadaScientific and Regulatory Perspectives
EditorialCRC Press
Páginas25-47
Número de páginas23
ISBN (versión digital)9780849355530
ISBN (versión impresa)9780824725389
EstadoPublished - ene 1 2006

ASJC Scopus subject areas

  • General Pharmacology, Toxicology and Pharmaceutics
  • General Health Professions
  • General Medicine

Huella

Profundice en los temas de investigación de 'Drug interactions with botanical products'. En conjunto forman una huella única.

Citar esto